Lampros Mitrakas
Overview
Explore the profile of Lampros Mitrakas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Samara M, Thodou E, Apostolopoulou C, Vlachostergios P, Mitrakas L, Zachos I, et al.
Acta Cytol
. 2024 Sep;
68(6):532-543.
PMID: 39312895
Introduction: Urine cytology using the Paris system (TPS) classification is useful for the detection and monitoring of bladder urothelial carcinoma (UC). However, the categories "atypical urothelial cells" (AUCs) and "suspicious...
2.
Vlachostergios P, Papathanassiou M, Anagnostou M, Thodou E, Tamposis I, Mitrakas L, et al.
F1000Res
. 2024 Jun;
12:918.
PMID: 38933491
Background: The risk of recurrence after nephrectomy for primary clear cell renal cell carcinoma (ccRCC) is estimated in daily practice solely based on clinical criteria. The aim of this study...
3.
Samara M, Vlachostergios P, Thodou E, Zachos I, Mitrakas L, Evmorfopoulos K, et al.
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003433
Bladder carcinoma is globally among the most prevalent cancers and is associated with a high mortality rate at advanced stages. Its detection relies on invasive diagnostic methods that are unpleasant...
4.
Zachos I, Vlachostergios P, Mitrakas L, Karatzas A, Oeconomou A, Mamoulakis C, et al.
Urol Ann
. 2023 Sep;
15(3):315-319.
PMID: 37664097
Background: This single-center, retrospective study was performed to investigate the safety and efficacy of radiofrequency-assisted (RF), laparoscopic partial nephrectomy (PN) with zero ischemia in patients with low-complexity small renal tumors....
5.
Evmorfopoulos K, Mitrakas L, Karathanasis A, Zachos I, Tzortzis V, Vlachostergios P
Biomedicines
. 2023 Jul;
11(7).
PMID: 37509415
Upper tract urothelial carcinoma (UTUC) is a rare malignancy, occurring in 5-10% of patients diagnosed with UC, and involves the renal pelvis, calyces, or ureters. UTUC can be sporadic or...
6.
Papathanassiou M, Tamposis I, Exarchou-Kouveli K, Kontou P, de Paz A, Mitrakas L, et al.
Front Oncol
. 2022 Dec;
12:996553.
PMID: 36531034
Introduction: The use of immune checkpoint inhibitors (ICIs) as a front-line treatment for metastatic renal cell carcinoma (RCC) has significantly improved patient' outcome. However, little is known about the efficacy...
7.
Vlachostergios P, Tamposis I, Anagnostou M, Papathanassiou M, Mitrakas L, Zachos I, et al.
Curr Oncol
. 2022 Nov;
29(11):8638-8649.
PMID: 36421334
Hypoxia is recognized as a key feature of cancer growth and is involved in various cellular processes, including proliferation, angiogenesis, and immune surveillance. Besides hypoxia-inducible factor 1-alpha (HIF-1α), which is...
8.
Mitsogiannis I, Mitsogianni M, Papathanassiou M, Anagnostou M, Tamposis I, Mitrakas L, et al.
J Kidney Cancer VHL
. 2022 Oct;
9(3):29-40.
PMID: 36310639
Standard systemic therapy of advanced renal cell carcinoma (RCC) involves targeting angiogenesis, mainly through tyrosine kinase inhibitors (TKI) against the vascular endothelial growth factor receptor (VEGFR) pathway and targeting the...
9.
Zachos I, Mitrakas L, Karasavvidou F, Karatzas A, Tzortzis V
J Surg Case Rep
. 2022 Oct;
2022(10):rjac475.
PMID: 36299912
Renal cell carcinoma (RCC) is the most frequent solid lesion accounting for ~90% of all kidney malignancies. Clear-cell RCC (ccRCC) represents the most frequent subtype. Urinary bladder is a rare...
10.
Karasavvidou F, Mitrakas L, Tzika S, Zachos I, Anagnostou A, Tzortzis V
J Surg Case Rep
. 2022 Sep;
2022(9):rjac387.
PMID: 36105648
The mixed epithelial and stromal tumor family of kidney contain neoplasms with biphasic epithelial and stromal component. According to the 2016 World Health Organization Classification, they encompasses a spectrum of...